CytoSorbents Corp (CTSO)-医療機器分野:企業M&A・提携分析

◆英語タイトル:CytoSorbents Corp (CTSO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012956
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that specializes in the development of blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme systemic inflammation in seriously ill patients by reducing excessive cytokines and bacterial toxins. CytoSorb is also being administered during and after cardiac surgery to prevent post-operative complications such as multiple organ failure. The company offers VetResQ, a blood purification adsorber, to help treat excessive inflammation and toxic injury in animals. The company offers its products through a network of distributors across Europe, the Middle East and Asia Pacific. CytoSorbents is headquartered in Monmouth Junction, New Jersey, the US.

CytoSorbents Corp (CTSO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
CytoSorbents Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
CytoSorbents Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
CytoSorbents Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
CytoSorbents Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
CytoSorbents Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
CytoSorbents Corp, Medical Equipment, Deal Details 11
Partnerships 11
CytoSorbents Enters into Agreement with Dr. Reddy’s Labs 11
CytoSorbents Enters into Distribution Agreement with Armaghan Salamat Kish 12
Terumo Cardiovascular Enters into Agreement with CytoSorbents 13
CytoSorbents Partners with NHLBI for HemoDefend 14
CytoSorbents Enters Into Research Agreement With University of Pennsylvania School Of Veterinary Medicine 15
Equity Offering 16
CytoSorbents Raises USD10 Million in Public Offering of Shares 16
CytoSorbents Raises USD10 Million in Public Offering of Shares 18
CytoSorbents Completes Private Placement Of Units For US$10.2 Million 19
CytoSorbents Completes Private Placement Of Common Stock For US$4 Million 20
CytoSorbents Completes Private Placement of Common Stock For US$2.9 Million 21
Debt Offering 22
CytoSorbents Completes Private Placement Of Notes Due 2014 For US$1.1 Million 22
CytoSorbents Corp – Key Competitors 23
CytoSorbents Corp – Key Employees 24
CytoSorbents Corp – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Strategy And Business Planning 26
May 06, 2016: CytoSorbents Establishes Swiss Subsidiary 26
Financial Announcements 27
Nov 09, 2017: CytoSorbents Continues Strong Trajectory of Growth in the Third Quarter 2017 27
Aug 07, 2017: CytoSorbents Reports Record Quarterly Total Revenue and Product Sales in the Second Quarter 2017 32
May 08, 2017: CytoSorbents Reports First Quarter 2017 Financial Results 36
Mar 03, 2017: CytoSorbents Reports Record Quarterly and Full-Year 2016 Revenue 37
Jan 10, 2017: CytoSorbents Pre-announces Q4 2016 and Full-Year 2016 Results 38
Nov 07, 2016: CytoSorb Q3 2016 Sales Reach Record $2.14M, Doubling From a Year Ago 39
Aug 09, 2016: CytoSorbents Achieves Fourth Consecutive Quarter of Record CytoSorb Sales 40
May 09, 2016: CytoSorbents Continues Strong Growth in Q1 2016 41
Mar 09, 2016: CytoSorbents Reports Record Quarterly and Full-Year 2015 Revenue 44
Corporate Communications 45
Jul 05, 2017: CytoSorbents Receives Additional $5 Million in Non-Dilutive Debt Financing from Bridge Bank 45
May 30, 2017: Dr. Eric G. Mortensen, M.D., Ph.D., Clinical Trial Veteran, Joins CytoSorbents as Chief Medical Officer 46
Mar 22, 2017: Dr. Carl H. June, Cancer Immunotherapy Pioneer, Joins Cytosorbents Scientific Advisory Board 47
Nov 15, 2016: Adrian Thomas Joins CytoSorbents to Drive Western European Sales 48
Product News 49
Sep 05, 2017: Cytosorbents Highlights Important Research Advances in Traumatic Brain Injury, Hemorrhagic Shock, and Severe Hyperkalemia at the Military Health System Research Symposium 49
Mar 08, 2017: Cytosorbents Highlights Activities At The 22nd International Conference On Advances In Critical Care Nephrology 51
03/16/2016: CytoSorbents Reports on Successful 3rd International CytoSorb Users Meeting 52
02/26/2016: Data Presented on First CytoSorb Investigator-Initiated Septic Shock Study 53
02/16/2016: CytoSorbents Announces 26th Symposium for Intensive Medicine and Intensive Care Agenda in Bremen, Germany 54
01/21/2016: CytoSorbents Appoints Dr. Volker Humbert as Senior Manager of Clinical Affairs 55
Other Significant Developments 56
Jul 13, 2017: CytoSorbents Awarded $1 Million STTR Phase II Contract To Advance Development of Life-Saving Universal Plasma 56
Aug 08, 2016: CytoSorbents Awarded $650,000 in SBIR Grant Contracts to Continue Development of Novel Hemocompatible Potassium Binding Polymers 57
Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58

List of Tables
CytoSorbents Corp, Medical Equipment, Key Facts, 2016 2
CytoSorbents Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
CytoSorbents Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
CytoSorbents Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
CytoSorbents Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
CytoSorbents Corp, Deals By Market, 2011 to YTD 2017 9
CytoSorbents Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
CytoSorbents Enters into Agreement with Dr. Reddy's Labs 11
CytoSorbents Enters into Distribution Agreement with Armaghan Salamat Kish 12
Terumo Cardiovascular Enters into Agreement with CytoSorbents 13
CytoSorbents Partners with NHLBI for HemoDefend 14
CytoSorbents Enters Into Research Agreement With University of Pennsylvania School Of Veterinary Medicine 15
CytoSorbents Raises USD10 Million in Public Offering of Shares 16
CytoSorbents Raises USD10 Million in Public Offering of Shares 18
CytoSorbents Completes Private Placement Of Units For US$10.2 Million 19
CytoSorbents Completes Private Placement Of Common Stock For US$4 Million 20
CytoSorbents Completes Private Placement of Common Stock For US$2.9 Million 21
CytoSorbents Completes Private Placement Of Notes Due 2014 For US$1.1 Million 22
CytoSorbents Corp, Key Competitors 23
CytoSorbents Corp, Key Employees 24
CytoSorbents Corp, Subsidiaries 25

★海外企業調査レポート[CytoSorbents Corp (CTSO)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Zuger Kantonalbank AG:企業の戦略・SWOT・財務分析
    Zuger Kantonalbank AG - Strategy, SWOT and Corporate Finance Report Summary Zuger Kantonalbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Young & Co.’s Brewery plc (YNGA):企業の財務・戦略的SWOT分析
    Young & Co.'s Brewery plc (YNGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Cohera Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Cohera Medical Inc (Cohera) is a medical device company that designs and develops surgical adhesives and sealants. The company’s products include TissuGlu surgical adhesive, and Sylys surgical sealant. Its TissuGlu surgical adhesive is biocompatible for internal use, and forms a bond between …
  • Fuji Seal International Inc.:企業の戦略・SWOT・財務情報
    Fuji Seal International Inc. - Strategy, SWOT and Corporate Finance Report Summary Fuji Seal International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Encompass Digital Media, Inc.:企業の戦略・SWOT・財務情報
    Encompass Digital Media, Inc. - Strategy, SWOT and Corporate Finance Report Summary Encompass Digital Media, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Concept Packaging Group:企業の戦略・SWOT・財務分析
    Concept Packaging Group - Strategy, SWOT and Corporate Finance Report Summary Concept Packaging Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • hVIVO Plc (HVO):企業の財務・戦略的SWOT分析
    Summary hVIVO Plc (hVIVO), formerly Retroscreen Virology Ltd is a biopharma company that develops human-based analytical platform to accelerate drug discovery and development. The company enables organisations to discover drugs and diagnostics and accelerate new product development. It uses human di …
  • EDF Energy Holdings Ltd:企業の戦略的SWOT分析
    EDF Energy Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Triveni Turbine Ltd (TRITURBINE):企業の財務・戦略的SWOT分析
    Triveni Turbine Ltd (TRITURBINE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Silicon Valley Bank:企業のM&A・事業提携・投資動向
    Silicon Valley Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Silicon Valley Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Camlin Fine Sciences Limited:戦略・SWOT・企業財務分析
    Camlin Fine Sciences Limited - Strategy, SWOT and Corporate Finance Report Summary Camlin Fine Sciences Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • CMIC Holdings Co Ltd (2309):製薬・医療:M&Aディール及び事業提携情報
    Summary CMIC Holdings Co Ltd (CMIC) is a contract research organization that supports drug development services. The organization offers medical research related services to pharmaceuticals and medical organizations. Its CRO business services include monitoring, data management, STAT analysis, regis …
  • GraceKennedy Ltd (GK):企業の財務・戦略的SWOT分析
    GraceKennedy Ltd (GK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • NTT DOCOMO Inc:企業の戦略・SWOT・財務分析
    NTT DOCOMO Inc - Strategy, SWOT and Corporate Finance Report Summary NTT DOCOMO Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Thornton & Ross Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Thornton & Ross Ltd (Thornton & Ross), a subsidiary of Stada Arzneimittel AG is a supplier of medicines and healthcare products. The company offers over the counter pharmaceutical products. It also manufactures pharmaceutical creams, liquids and semi-solids. Thornton & Ross’ products compris …
  • BP Australia Group Pty Ltd:企業の戦略的SWOT分析
    BP Australia Group Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Clementia Pharmaceuticals Inc (CMTA)-製薬・医療分野:企業M&A・提携分析
    Summary Clementia Pharmaceuticals Inc (Clementia) is a biopharmaceutical company that develops and commercializes orphan drugs and therapies. The company’s palovarotene is used for treatment of muscle tissue disorders such as fibrodysplasia ossificans progressive and other diseases. Its palovarotene …
  • AlloSource:企業の戦略的SWOT分析
    AlloSource - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Eesti Energia AS-エネルギー分野:企業M&A・提携分析
    Summary Eesti Energia AS (Eesti Energia) is an international energy company that offers energy solutions ranging from electricity, heat and fuel production to sales, customer service and ancillary energy services among others. Eesti Energia sells electricity to the Baltic retail customers and the wh …
  • KeyCorp (KEY):電力:M&Aディール及び事業提携情報
    Summary KeyCorp (KeyCorp) is a bank holding company that offers a range of retail and commercial banking, consumer finance, commercial mortgage and special servicing, commercial leasing, investment management, and investment banking products and services through its principle subsidiary, KeyBank Nat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆